Literature DB >> 34042322

Expansion of Fcγ Receptor IIIa-Positive Macrophages, Ficolin 1-Positive Monocyte-Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis.

Dan Xue1, Tracy Tabib2, Christina Morse2, Yi Yang3, Robyn T Domsic2, Dinesh Khanna4, Robert Lafyatis2.   

Abstract

OBJECTIVE: In this study, we sought a comprehensive understanding of myeloid cell types driving fibrosis in diffuse cutaneous systemic sclerosis (dcSSc) skin.
METHODS: We analyzed the transcriptomes of 2,465 myeloid cells from skin biopsy specimens from 12 dcSSc patients and 10 healthy control subjects using single-cell RNA sequencing. Monocyte-derived dendritic cells (mo-DCs) were assessed using immunohistochemical staining and immunofluorescence analyses targeting ficolin-1 (FCN-1).
RESULTS: A t-distributed stochastic neighbor embedding analysis of single-cell transcriptome data revealed 12 myeloid cell clusters, 9 of which paralleled previously described healthy control macrophage/DC clusters, and 3 of which were dcSSc-specific myeloid cell clusters. One SSc-associated macrophage cluster, highly expressing Fcγ receptor IIIA, was suggested on pseudotime analysis to be derived from normal CCR1+ and MARCO+ macrophages. A second SSc-associated myeloid population highly expressed monocyte markers FCN-1, epiregulin, S100A8, and S100A9, but was closely related to type 2 conventional DCs on pseudotime analysis and identified as mo-DCs. Mo-DCs were associated with more severe skin disease. Proliferating macrophages and plasmacytoid DCs were detected almost exclusively in dcSSc skin, the latter clustering with B cells and apparently derived from lymphoid progenitors.
CONCLUSION: Transcriptional signatures in these and other myeloid populations indicate innate immune system activation, possibly through Toll-like receptors and highly up-regulated chemokines. However, the appearance and activation of myeloid cells varies between patients, indicating potential differences in the underlying pathogenesis and/or temporal disease activity in dcSSc.
© 2021, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34042322      PMCID: PMC8626521          DOI: 10.1002/art.41813

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  41 in total

1.  Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis.

Authors:  Christina Morse; Tracy Tabib; John Sembrat; Kristina L Buschur; Humberto Trejo Bittar; Eleanor Valenzi; Yale Jiang; Daniel J Kass; Kevin Gibson; Wei Chen; Ana Mora; Panayiotis V Benos; Mauricio Rojas; Robert Lafyatis
Journal:  Eur Respir J       Date:  2019-08-22       Impact factor: 16.671

2.  SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin.

Authors:  Tracy Tabib; Christina Morse; Ting Wang; Wei Chen; Robert Lafyatis
Journal:  J Invest Dermatol       Date:  2017-12-06       Impact factor: 8.551

3.  Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages.

Authors:  B M Kräling; G G Maul; S A Jimenez
Journal:  Pathobiology       Date:  1995       Impact factor: 4.342

4.  The chemotaxis of M1 and M2 macrophages is regulated by different chemokines.

Authors:  Wenjuan Xuan; Qing Qu; Biao Zheng; Sidong Xiong; Guo-Huang Fan
Journal:  J Leukoc Biol       Date:  2014-10-30       Impact factor: 4.962

5.  Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.

Authors:  Dinesh Khanna; Christopher P Denton; Angelika Jahreis; Jacob M van Laar; Tracy M Frech; Marina E Anderson; Murray Baron; Lorinda Chung; Gerhard Fierlbeck; Santhanam Lakshminarayanan; Yannick Allanore; Janet E Pope; Gabriela Riemekasten; Virginia Steen; Ulf Müller-Ladner; Robert Lafyatis; Giuseppina Stifano; Helen Spotswood; Haiyin Chen-Harris; Sebastian Dziadek; Alyssa Morimoto; Thierry Sornasse; Jeffrey Siegel; Daniel E Furst
Journal:  Lancet       Date:  2016-05-05       Impact factor: 79.321

Review 6.  Wound macrophages as key regulators of repair: origin, phenotype, and function.

Authors:  Samielle K Brancato; Jorge E Albina
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.

Authors:  Allison L Mathes; Romy B Christmann; Giuseppina Stifano; Alsya J Affandi; Timothy R D J Radstake; G Alessandra Farina; Cristina Padilla; Sarah McLaughlin; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

8.  Integrating single-cell transcriptomic data across different conditions, technologies, and species.

Authors:  Andrew Butler; Paul Hoffman; Peter Smibert; Efthymia Papalexi; Rahul Satija
Journal:  Nat Biotechnol       Date:  2018-04-02       Impact factor: 54.908

9.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.

Authors:  Alexandra-Chloé Villani; Rahul Satija; Gary Reynolds; Siranush Sarkizova; Karthik Shekhar; James Fletcher; Morgane Griesbeck; Andrew Butler; Shiwei Zheng; Suzan Lazo; Laura Jardine; David Dixon; Emily Stephenson; Emil Nilsson; Ida Grundberg; David McDonald; Andrew Filby; Weibo Li; Philip L De Jager; Orit Rozenblatt-Rosen; Andrew A Lane; Muzlifah Haniffa; Aviv Regev; Nir Hacohen
Journal:  Science       Date:  2017-04-21       Impact factor: 47.728

10.  Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis.

Authors:  Giuseppina Stifano; Alsya J Affandi; Allison L Mathes; Lisa M Rice; Sashidhar Nakerakanti; Banafsheh Nazari; Jungeun Lee; Romy B Christmann; Robert Lafyatis
Journal:  Arthritis Res Ther       Date:  2014-07-01       Impact factor: 5.156

View more
  6 in total

1.  Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time.

Authors:  Brian Skaug; Marka A Lyons; William R Swindell; Gloria A Salazar; Minghua Wu; Tuan M Tran; Julio Charles; Connor P Vershel; Maureen D Mayes; Shervin Assassi
Journal:  Ann Rheum Dis       Date:  2021-12-22       Impact factor: 19.103

Review 2.  Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.

Authors:  Theodoros-Ioannis Papadimitriou; Arjan van Caam; Peter M van der Kraan; Rogier M Thurlings
Journal:  Biomedicines       Date:  2022-01-29

Review 3.  Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights.

Authors:  Bingying Dai; Liqing Ding; Lijuan Zhao; Honglin Zhu; Hui Luo
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

Review 4.  Targeting fibrosis, mechanisms and cilinical trials.

Authors:  Manyu Zhao; Liqun Wang; Mengzhu Wang; Shijie Zhou; Ying Lu; Huijie Cui; Alexandra C Racanelli; Ling Zhang; Tinghong Ye; Bisen Ding; Ben Zhang; Jinliang Yang; Yuqin Yao
Journal:  Signal Transduct Target Ther       Date:  2022-06-30

Review 5.  Single-cell transcriptomics in human skin research: available technologies, technical considerations and disease applications.

Authors:  Georgios Theocharidis; Stavroula Tekkela; Aristidis Veves; John A McGrath; Alexandros Onoufriadis
Journal:  Exp Dermatol       Date:  2022-03-04       Impact factor: 4.511

Review 6.  Single Cell RNA Sequencing in Autoimmune Inflammatory Rheumatic Diseases: Current Applications, Challenges and a Step Toward Precision Medicine.

Authors:  Tadeja Kuret; Snežna Sodin-Šemrl; Brane Leskošek; Polonca Ferk
Journal:  Front Med (Lausanne)       Date:  2022-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.